EVH - Evolent Health, Inc.
NEXT EARNINGS:
May 6, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.00
DETAILS
HIGH:
$10.00
LOW:
$6.00
MEDIAN:
$8.00
CONSENSUS:
$8.00
UPSIDE:
212.50%
Market Cap:
296.89M
Volume:
4,512,297
Avg Volume:
2,979,200
52 Week Range:
2.52-12.065
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
0.24
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
4,500
IPO Date:
2015-06-05
EPS (TTM):
-0.81
P/E Ratio:
-0.79
Revenue (TTM):
2.55B
Total Assets:
2.54B
Total Debt:
713.67M
Cash & Equiv:
104.20M
Rev Growth (5Y):
30.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-2.1%
Debt/Equity:
0.71
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-06 | $0.05 | $0.10 | -50.0% | $479.5M | $468.5M | +2.4% |
| 2025-08-07 | $-0.10 | $0.09 | -211.1% | $444.3M | $532.2M | -16.5% |
| 2025-05-08 | $0.06 | $0.09 | -33.3% | $483.6M | $460.3M | +5.1% |
| 2025-02-20 | $-0.02 | $0.38 | -105.3% | $646.5M | $650.9M | -0.7% |
| 2024-11-07 | $0.04 | $0.30 | -86.7% | $621.4M | $652.2M | -4.7% |
| 2024-08-08 | $0.30 | $0.21 | +42.9% | $647.1M | $636.4M | +1.7% |
| 2024-05-09 | $0.34 | $0.21 | +61.9% | $639.7M | $600.3M | +6.6% |
| 2024-02-22 | $0.23 | $0.11 | +109.1% | $556.1M | $542.4M | +2.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.55B | 1.96B | 1.35B | 907.96M | 924.64M | 687.12M | 627.06M | 434.95M | 254.19M | 96.88M | 0 | 25.67M |
| Net Income | (61.62M) | (113.04M) | (19.16M) | (37.60M) | (334.25M) | (301.97M) | (52.66M) | (60.66M) | (159.74M) | 332.49M | (25.25M) | 20.02M |
| EPS | -0.81 | -1.28 | -0.20 | -0.36 | -3.94 | -3.71 | -0.68 | -0.94 | -3.55 | 8.03 | -0.66 | 0.06 |
| Total Assets | 2.54B | 2.68B | 1.82B | 1.42B | 1.47B | 1.50B | 1.72B | 1.31B | 1.20B | 1.02B | 38.28M | 101.97M |
| Total Debt | 713.67M | 644.80M | 476.12M | 280.47M | 359.78M | 368.79M | 221.04M | 121.39M | 120.28M | 0 | 0 | 0 |
| Cash & Equivalents | 104.20M | 192.82M | 188.20M | 266.28M | 333.38M | 101.01M | 228.32M | 238.43M | 134.56M | 145.73M | 0 | 67.89M |
| Operating Cash Flow | 18.77M | 142.58M | (11.55M) | 38.75M | (16.23M) | (42.65M) | (20.65M) | (27.96M) | (35.51M) | (19.83M) | (75.09M) | (13.63M) |
| Free Cash Flow | (6.13M) | 113.84M | (49.91M) | 13.76M | (45.70M) | (78.18M) | (60.20M) | (55.81M) | (51.04M) | (26.34M) | (86.13M) | (24.07M) |
| FCF per Share | -0.05 | 1.02 | -0.53 | 0.16 | -0.54 | -0.95 | -0.78 | -0.87 | -1.13 | -0.64 | -2.25 | -0.63 |
| Book Value | 1.00B | 1.07B | 859.42M | 693.63M | 619.60M | 922.36M | 1.14B | 1.01B | 702.53M | 649.34M | (2.07M) | 31.04M |
| Cash & ST Investments | 163.50M | 192.82M | 188.20M | 266.28M | 333.38M | 102.81M | 228.32M | 238.43M | 178.90M | 155.17M | 0 | 67.89M |
| ROC Equity | -0.06 | -0.11 | -0.02 | -0.05 | -0.54 | -0.33 | -0.05 | -0.06 | -0.23 | 0.51 | N/A | 0.64 |